# US 2003/0232371 A1 · Methods for detecting methylated promoters based on differential DNA methylation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0232371 A1
- Document ID: US20030232371A1
- Status: Published application
- Kind: A1
- Application number: 10/422,566
- Filed: 2003-04-24
- Published: 2003-12-18
- Earliest claimed: 2001-10-24
- Inventors: Timothy H. Bestor
- Web page: https://patentgrep.com/patent/US20030232371A1

## CPC

- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/683: involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

This invention provides a method for detecting the presence of differential methylation between DNA comprising all or a portion of a promoter from a first source and the corresponding DNA from a second source. Also provided are methods for determining whether a promoter is methylated.

## Claims

### Claim 1

A method for detecting the presence of differential methylation between DNA comprising all or a portion of a promoter from a first source and the corresponding DNA from a second source, which method comprises the steps of:
(a) (i) contacting an agent that degrades methylated DNA with a sample of the DNA from the first source, under suitable conditions, so as to degrade methylated DNA in the first sample, and (ii) contacting an agent that degrades unmethylated DNA with a sample of the DNA from the second source, under suitable conditions, so as to degrade unmethylated DNA in the second sample;
(b) contacting the resulting samples with each other under conditions permitting reannealing between the DNA strands therein, so as to permit the formation of a hybrid DNA duplex comprising a DNA strand from the first source and a DNA strand from the second source, should both such strands be present; and
(c) detecting the formation of any such hybrid DNA duplex, such formation indicating the presence of differential methylation between the DNA from the first source and the corresponding DNA from the second source.

### Claim 2 (depends on 1)

The method of claim 1, further comprising the step of modifying the DNA of parts (i) and (ii) resulting from step (a) with a first and second moiety, respectively, so as to prevent, in step (b), the formation of a DNA duplex consisting of DNA strands from the first source or of a DNA duplex consisting of DNA strands from the second source.

### Claim 3 (depends on 2)

The method of claim 2, wherein the modification of at least one sample resulting from step (a) comprises modifying the DNA in at least one sample with a moiety which facilitates the isolation of hybrid DNA duplexes formed in step (b).

### Claim 4 (depends on 3)

The method of claim 3, wherein the moiety is biotin.

### Claim 5 (depends on 1)

The method of claim 1, further comprising the step of determining the nucleic acid sequence of a hybrid DNA duplex whose presence is detected in step (c).

### Claim 6 (depends on 5)

The method of claim 5, further comprising the step of identifying the methylated nucleotide residues of one or both strands of the hybrid DNA duplex whose sequence is determined.

### Claim 7 (depends on 1)

The method of claim 1, wherein the first and second sources of DNA are a cell from a first tissue of a subject and a cell from a second tissue of that subject, respectively.

### Claim 8 (depends on 1)

The method of claim 1, wherein the first and second sources of DNA are a cell from a normal tissue and a cell from that tissue in a diseased state, respectively.

### Claim 9 (depends on 1)

The method of claim 1, wherein the first and second sources of DNA are both chromosomes of a chromosome pair.

### Claim 10 (depends on 1)

The method of claim 1, wherein each of the DNA samples from the first and second sources consists of all or a portion of a promoter.

### Claim 11 (depends on 10)

The method of claim 10, wherein the promoter is a promoter for a tumor suppressor gene.

### Claim 12 (depends on 10)

The method of claim 10, wherein the promoter is a promoter for an oncogene.

### Claim 13 (depends on 1)

The method of claim 1, wherein the agent that degrades methylated DNA is McrBC.

### Claim 14 (depends on 1)

The method of claim 1, wherein the agent that degrades unmethylated DNA comprises a methylation-sensitive restriction endonuclease.

### Claim 15 (depends on 14)

The method of claim 14, wherein the methylation-sensitive restriction endonuclease is selected from the group consisting of HpaII, HhaI, MaeII, BstUI and AciI.

### Claim 16 (depends on 1)

The method of claim 1, wherein the agent that degrades unmethylated DNA comprises a plurality of methylation-sensitive restriction endonucleases.

### Claim 17 (depends on 15)

The method of claim 15, wherein the plurality of methylation-sensitive restriction endonucleases is selected from the group consisting of HpaII, HhaI, MaeII, BstUI and AciI.

### Claim 18 (depends on 1)

The method of claim 1, wherein the DNA from the first and second sources is human DNA.

### Claim 19

A method for determining whether a promoter is methylated, which method comprises the steps of:
(a) (i) contacting an agent that degrades unmethylated DNA with a first sample of DNA comprising all or a portion of the promoter, under suitable conditions, so as to degrade unmethylated DNA in the sample, and (ii) contacting an agent that degrades methylated DNA with a second sample of DNA corresponding to the first, under suitable conditions, so as to degrade methylated DNA in the sample, wherein the DNA in the second sample is known to be unmethylated;
(b) contacting the resulting samples with each other under conditions permitting reannealing between the DNA strands therein, so as to permit the formation of a hybrid DNA duplex comprising a DNA strand from the first sample and a DNA strand from the second sample, should both such strands be present; and
(c) detecting the formation of any such hybrid DNA duplex, such formation indicating the presence of differential methylation between the DNA from the first sample and the corresponding DNA from the second, and hence indicating that the promoter is methylated.

### Claim 20 (depends on 19)

The method of claim 19, further comprising the step of modifying the DNA of parts (i) and (ii) resulting from step (a) with a first and second moiety, respectively, so as to prevent, in step (b), the formation of a DNA duplex consisting of DNA strands from the first sample or of a DNA duplex consisting of DNA strands from the second sample.

### Claim 21 (depends on 20)

The method of claim 20, wherein the modification of at least one sample resulting from step (a) comprises modifying the DNA in at least one sample with a moiety which facilitates the isolation of hybrid DNA duplexes formed in step (b).

### Claim 22 (depends on 21)

The method of claim 21, wherein the moiety is biotin.

### Claim 23 (depends on 19)

The method of claim 19, further comprising the step of determining the nucleic acid sequence of a hybrid DNA duplex whose presence is detected in step (c).

### Claim 24 (depends on 23)

The method of claim 23, further comprising the step of identifying the methylated nucleotide residues of one or both strands of the hybrid DNA duplex whose sequence is determined.

### Claim 25 (depends on 19)

The method of claim 19, wherein the agent that degrades methylated DNA is McrBC.

### Claim 26 (depends on 19)

The method of claim 19, wherein the agent that degrades unmethylated DNA comprises a methylation-sensitive restriction endonuclease.

### Claim 27 (depends on 26)

The method of claim 26, wherein the methylation-sensitive restriction endonuclease is selected from the group consisting of HpaII, HhaI, MaeII, BstUI and AciI.

### Claim 28 (depends on 19)

The method of claim 19, wherein the agent that degrades unmethylated DNA comprises a plurality of methylation-sensitive restriction endonucleases.

### Claim 29 (depends on 28)

The method of claim 28, wherein the plurality of methylation-sensitive restriction endonucleases is selected from the group consisting of HpaII, HhaI, MaeII, BstUI and AciI.

### Claim 30 (depends on 19)

The method of claim 19, wherein the first and second samples are from a human being.

### Claim 31 (depends on 19)

The method of claim 19, wherein the first sample is from a human being known to be afflicted with a disorder.

### Claim 32 (depends on 31)

The method of claim 31, wherein the disorder is cancer.

### Claim 33 (depends on 19)

The method of claim 19, wherein the promoter is a promoter for a tumor suppressor gene.

### Claim 34 (depends on 19)

The method of claim 19, wherein the promoter is a promoter for an oncogene.

### Claim 35 (depends on 19)

The method of claim 19, wherein the first and second samples consist of all or a portion of a promoter.

### Claim 36

A method for determining whether a promoter is methylated, which method comprises the steps of:
(a) (i) contacting a first sample of DNA comprising all or a portion of the promoter with an agent that degrades unmethylated DNA, under suitable conditions, so as to degrade unmethylated DNA in the sample;
(b) contacting the resulting first sample with a second sample of corresponding DNA, known to be unmethylated, under conditions permitting reannealing between the DNA strands therein, so as to permit the formation of a hybrid DNA duplex comprising a DNA strand from the first sample and a DNA strand from the second sample, should both such strands be present; and
(c) detecting the formation of any such hybrid DNA duplex, such formation indicating the presence of differential methylation between the DNA from the first sample and the corresponding DNA from the second, and hence indicating that the promoter is methylated.

### Claim 37 (depends on 36)

The method of claim 36, further comprising the step of modifying the DNA of the first and second samples with a first and second moiety, respectively, so as to prevent, in step (b), the formation of a DNA duplex consisting of DNA strands from the first sample or of a DNA duplex consisting of DNA strands from the second sample.

### Claim 38 (depends on 37)

The method of claim 37, wherein the modification comprises modifying the DNA in at least one sample with a moiety which facilitates the isolation of hybrid DNA duplexes formed in step (b).

### Claim 39 (depends on 38)

The method of claim 38, wherein the moiety is biotin.

### Claim 40 (depends on 36)

The method of claim 36, further comprising the step of determining the nucleic acid sequence of a hybrid DNA duplex whose presence is detected in step (c).

### Claim 41 (depends on 40)

The method of claim 40, further comprising the step of identifying the methylated nucleotide residues of a strand of the hybrid DNA duplex whose sequence is determined.

### Claim 42 (depends on 36)

The method of claim 36, wherein the agent that degrades unmethylated DNA comprises a methylation-sensitive restriction endonuclease.

### Claim 43 (depends on 42)

The method of claim 42, wherein the methylation-sensitive restriction endonuclease is selected from the group consisting of HpaII, HhaI, MaeII, BstUI and AciI.

### Claim 44 (depends on 36)

The method of claim 36, wherein the agent that degrades unmethylated DNA comprises a plurality of methylation-sensitive restriction endonucleases.

### Claim 45 (depends on 44)

The method of claim 44, wherein the plurality of methylation-sensitive restriction endonucleases is selected from the group consisting of HpaII, HhaI, MaeII, BstUI and AciI.

### Claim 46 (depends on 36)

The method of claim 36, wherein the first and second samples are from a human being.

### Claim 47 (depends on 36)

The method of claim 36, wherein the first sample is from a human being known to be afflicted with a disorder.

### Claim 48 (depends on 47)

The method of claim 47, wherein the disorder is cancer.

### Claim 49 (depends on 36)

The method of claim 36, wherein the promoter is a promoter for a tumor suppressor gene.

### Claim 50 (depends on 36)

The method of claim 36, wherein the promoter is a promoter for an oncogene.

### Claim 51 (depends on 36)

The method of claim 36, wherein the first and second samples consist of all or a portion of a promoter.
